Study faults FDA approval process

September 4, 2006

Seventy-nine percent of drugs and medical devices are approved by the FDA's outside advisory panels, according to a study conducted by National Research Center for Women & Families. The Washington-based nonprofit research group termed the committees as little more than "rubber stamps" for drug companies.

Study faults FDA approval process

Seventy-nine percent of drugs and medical devices are approved by the FDA's outside advisory panels, according to a study conducted by National Research Center for Women & Families. The Washington-based nonprofit research group termed the committees as little more than "rubber stamps" for drug companies. The study looked at 89 applications between 1998 and 2005 that were considered by 11 randomly selected advisory committees. In July the FDA announced it would take steps to strengthen the advisory committee processes with guidelines for "greater clarity and transparency" to reassure the public about the basic integrity of the process.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.